Search Within

Dermatology

  1. "Ahmet Dogan"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (8)
  3. Research Letter (1)
Groups
  1. Department of Medicine (22)
  2. Department of Pathology and Laboratory Medicine (22)
  3. Dermatology Service (22)
  4. Division of Subspecialty Medicine (22)
  5. Hematologic Malignancies, Division of (22)
  6. Center for Hematologic Malignancies (21)

More Groups

People
  1. Ahmet Dogan (22)
  2. Patricia Myskowski (15)
  3. Steven Horwitz (15)
  4. Alison Moskowitz (13)
  5. Natasha Galasso (11)
  6. Nivetha Ganesan (8)

More People

Years
  1. 2024 (3)
  2. 2023 (2)
  3. 2021 (3)
  4. 2020 (2)
  5. 2019 (2)
  6. 2018 (4)

More Years

Publications
  1. Blood (12)
  2. Haematologica (2)
  3. American Journal of Dermatopathology (1)
  4. Blood Cancer Journal (1)
  5. British Journal of Haematology (1)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Society of Hematology (12)
  2. American Association for Cancer Research (2)
  3. Ferrata Storti Foundation (2)
  4. Nature Publishing Group (2)
  5. Wiley Blackwell (2)
  6. John Wiley & Sons (1)

More Publishers

Results (22)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dual-targeted therapy with ruxolitinib plus duvelisib for T-cell lymphoma
    Meeting Abstract

    Moskowitz, A.; Ganesan, N.; Chang, T.; Davey, T.; Hancock, H.; Smith, M.; Assini, A.; Sarmasti, L.; Miller, T.; Gibaldi, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies
    Journal Article

    Krystel-Whittemore, M.; Petrova-Drus, K.; Ptashkin, R. N.; Ewalt, M. D.; Yao, J.; Liu, Y.; Zhu, M.; Benhamida, J.; Durham, B.; Kumar, J.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy
    Journal Article

    Friedman, J. S.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Dogan, A.; Pulitzer, M.; Busam, K. J.; Francis, J. H.; Rampal, R. K.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Phase 2 trial of single-agent cobimetinib for adults with histiocytic neoplasms
    Meeting Abstract

    Diamond, E. L.; Durham, B.; Dogan, A.; Yabe, M.; Petrova-Drus, K.; Rampal, R. K.; Ulaner, G.; Lacouture, M.; Rotemberg, V.; Covey, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A Rare case of primary cutaneous gamma-delta T-cell lymphoma with aberrant B-cell marker expression
    Journal Article

    Trivedi, A.; Yabe, M.; Dogan, A.; Epstein-Peterson, Z. D.; Myskowski, P. L.; Arcila, M. E.; Linos, K.
    American Journal of Dermatopathology (2023)

    Fulltext@MSK | Save
  • Clinical outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg type treated in the rituximab era: Long-term follow-up of a single-center experience
    Meeting Abstract

    Falchi, L.; Qiu, A.; Ewalt, M. D.; Batlevi, C. L.; Caron, P. C.; Hamlin, P. A.; Hamilton, A.; Horwitz, S. M.; Joffe, E.; Khan, N.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas
    Journal Article

    Moskowitz, A. J.; Ghione, P.; Jacobsen, E.; Ruan, J.; Schatz, J. H.; Noor, S.; Myskowski, P.; Vardhana, S.; Ganesan, N.; Hancock, H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • The combination of duvelisib and romidepsin (DR) is highly active against relapsed/refractory peripheral T‐cell lymphoma with low rates of transaminitis: Final results
    Meeting Abstract

    Horwitz, S. M.; Moskowitz, A. J.; Mehta‐Shah, N.; Jacobsen, E. D.; Khodadoust, M. S.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Myskowski, P.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Multispectral immunofluorescence identifies pS6 as a biomarker of intrinsic resistance to ruxolitinib in patients with relapsed/refractory T-cell lymphomas
    Meeting Abstract

    Ghione, P.; Moskowitz, A.; Kumar, P.; Knezevic, A.; Seshan, V.; Jacobsen, E.; Ruan, J.; Schatz, J.; Noor, S.; Myskowski, P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological features
    Research Letter

    Argyropoulos, K. V.; Pulitzer, M.; Maura, F.; Mohanty, A.; Mondello, P.; Horwitz, S. M.; Myskowski, P.; Moskowitz, A.; Dogan, A.; Querfeld, C.; more...
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save